CDSS Clinical Decision Support System Market – Global Forecast Till 2023

$4,450$6,250

CDSS Market: Component (Software), Product (Integrated CDSS), Model (Knowledge-Based CDSS) Delivery Mode (On-Premise CDSS), Mode of Advice (Active CDSS), Setting (Inpatient Setting), Type (Therapeutic CDSS), Application (Advanced CDSS) – Global Forecast Till 2023

Clear

Description

Introduction
A clinical decision support system (CDSS) is a health information technology system that is designed to assist physicians and other health professionals in clinical decision-making tasks. A CDSS is an adaptation of the decision support system commonly used to aid business management. The major factors driving the growth of the market include rising demand for data-driven technologies, increasing geriatric population, increasing number emergency cases, and development of healthcare infrastructure.
The global clinical decision support systems market is expected to reach a market value of USD 1764.93 million by 2023 from USD 794.10 million in 2016, growing at a CAGR of 12.0% during the forecast period. In 2016, the Americas held the highest share of the market, i.e., 39.3%, followed by Europe and Asia-Pacific with 34.3% and 19.4% market shares respectively.
The global clinical decision support systems market has been segmented on the basis of component, product, model, delivery mode, mode of advice, setting, type, application, and region.
The global clinical decision support systems market, by component, has been segmented into services, software, and hardware.
The global clinical decision support systems market, by product, has been segmented into integrated CDSS and standalone CDSS.
The global clinical decision support systems market, by model, has been segmented into Knowledge-Based CDSS and Non-Knowledge-Based CDSS.
By delivery mode, the global clinical decision support systems market has been segmented into on-premise and cloud-based systems.
By mode of advice, the global clinical decision support systems market has been segmented into passive CDSS and active CDSS.
By settings, the global clinical decision support systems market has been segmented into inpatient settings and ambulatory care settings.
By type, the global clinical decision support systems market has been segmented into therapeutic clinical decision support system and diagnostic clinical decision support system.
By application, the global clinical decision support systems market has been segmented into conventional clinical decision support systems and advanced clinical decision support systems.
The global clinical decision support systems market is expected to reach USD 1764.93 million by 2023 from USD 891.78 million in 2017; it is expected to register a CAGR of 12.0% during the forecast period from 2017 to 2023.
Key Players
Wolters Kluwer Health, Hearst Communications Inc., Elsevier B.V., Agfa-Gevaert Group, Athenahealth, Inc., Siemens AG, Carestream Health, Epic Systems, IBM Corporation, and Allscripts Healthcare Solutions.

Study objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the clinical decision support systems market
• To provide insights into factors affecting the market growth
• To analyze the global clinical decision support systems market based on various tools such as supply chain analysis and Porter’s five force analysis
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
• To provide country-level analysis of the market with respect to the current market size and future perspective
• To provide country-level analysis of the market for segments by component, product, model, delivery mode, mode of advice, setting, type, application, and region
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the clinical decision support systems market
Target Audience
• Hospitals
• Clinical Decision Support Systems Manufacturing Companies
Key Findings
• The global clinical decision support systems market is expected to reach USD 1764.93 million by 2023 at a CAGR of 12.0% from 2017 to 2023
• On the basis of component, software accounted for the largest market share at a CAGR of 12.11% by 2023
• On the basis of product, integrated CDSS accounted for the largest market share at a CAGR of 12.34% by 2023
• On the basis of model, knowledge-based CDSS accounted for the largest market share at a CAGR of 12.34% by 2023
• On the basis of delivery mode, on-premise CDSS accounted for the largest market share at a CAGR of 11.77% by 2023
• On the basis of mode of advice, active CDSS accounted for the largest market share at a CAGR of 12.34% by 2023
• On the basis of settings, inpatient settings accounted for the largest market share at a CAGR of 12.34% by 2023
• On the basis of type, therapeutic clinical decision support systems accounted for the largest market share at a CAGR of 12.34% by 2023
• On the basis of application, advanced clinical decision support systems accounted for the largest market share at a CAGR of 12.34% by 2023
• The Americas is expected to hold the largest share of the global clinical decision support systems market at a CAGR of 12.15% by 2023
• Asia-Pacific is the fastest growing market, which is expected to grow at a CAGR of 12.36% by 2023
Regional Analysis
• Americas
o North America
 US
 Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

Table of Contents

Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.4.3 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing geriatric population
4.2.2 Increasing number of hospitals
4.2.3 Growing demand for data-driven technologies
4.2.4 Increasing number of Emergency Department (ED) visits
4.3 Restraints
4.3.1 Risk of data privacy
4.3.2 High cost for the Implementation
4.3.3 Lack of skilled healthcare IT professionals
4.4 Opportunity
4.4.1 Advancements in the healthcare IT sector
4.5 Macroeconomics
4.6 Technology Trends
5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Investment Opportunity Analysis
5.3 Value Chain Analysis
5.3.1 Inputs
5.3.2 Software Development Processes
5.3.3 Output
5.3.4 Marketing & Distribution
5.3.5 Post-Selling Services
5.4 Pricing Analysis
6 Global Clinical Decision Support Systems Market, By Component
6.1 Introduction
6.2 Software
6.3 Services
6.4 Hardware
7 Global Clinical Decision Support Systems Market, By Product
7.1 Introduction
7.2 Integrated CDSS
7.3 Standalone CDSS
8 Global Clinical Decision Support Systems Market, By Model
8.1 Introduction
8.2 Knowledge-Based CDSS
8.3 Non-Knowledge-Based CDSS
9 Global Clinical Decision Support Systems Market, By Delivery Mode
9.1 Introduction
9.2 On-Premise CDSS
9.3 Cloud-Based CDSS
10 Global Clinical Decision Support Systems Market, By Mode of Advice
10.1 Introduction
10.2 Active CDSS
10.3 Passive CDSS
11 Global Clinical Decision Support Systems Market, By Setting
11.1 Introduction
11.2 Inpatient Settings
11.3 Ambulatory Care Settings
12 Global Clinical Decision Support Systems Market, By Type
12.1 Introduction
12.2 Therapeutic Clinical Decision Support Systems
12.3 Diagnostic Clinical Decision Support Systems
13 Global Clinical Decision Support Systems Market, By Application
13.1 Introduction
13.2 Advanced Clinical Decision Support Systems
13.3 Conventional Clinical Decision Support Systems
14 Global Clinical Decision Support Systems Market, By Region
14.1 Introduction
14.2 Americas
14.2.1 North America
14.2.1.1 U.S.
14.2.1.2 Canada
14.2.2 South America
14.3 Europe
14.3.1 Western Europe
14.3.1.1 Germany
14.3.1.2 France
14.3.1.3 U.K.
14.3.1.4 Italy
14.3.1.5 Spain
14.3.1.6 Rest of Western Europe
14.3.2 Eastern Europe
14.4 Asia Pacific
14.4.1 Japan
14.4.2 China
14.4.3 India
14.4.4 Australia
14.4.5 Republic of Korea
14.4.6 Rest of Asia Pacific
14.5 Middle East & Africa
14.5.1 Middle East
14.5.2 Africa
15 Competitive Landscape
15.1 Company Share Analysis
16 Company Profiles
16.1 Wolters Kluwer Health
16.1.1 Company Overview
16.1.2 Financial Overview
16.1.3 Products Offering
16.1.4 Key Developments
16.1.5 SWOT Analysis
16.1.6 Key Strategy
16.2 Hearst Communications Inc
16.2.1 Company Overview
16.2.2 Financial Overview
16.2.3 Products Offering
16.2.4 Key Developments
16.2.5 SWOT Analysis
16.2.6 Key Strategy
16.3 Elsevier B.V.
16.3.1 Company Overview
16.3.2 Financial Overview
16.3.3 Products Offering
16.3.4 Key Developments
16.3.5 SWOT Analysis
16.3.6 Key Strategy
16.4 Agfa-Gevaert Group
16.4.1 Company Overview
16.4.2 Financial Overview
16.4.3 Products Offering
16.4.4 Key Developments
16.4.5 SWOT Analysis
16.4.1 Key Strategy
16.5 Athenahealth, Inc
16.5.1 Company Overview
16.5.2 Financial Overview
16.5.3 Products Offering
16.5.4 Key Developments
16.5.5 SWOT Analysis
16.5.6 Key Strategy
16.6 Siemens AG
16.6.1 Company Overview
16.6.2 Financial Overview
16.6.3 Products Offering
16.6.4 Key Developments
16.6.5 SWOT Analysis
16.6.6 Key Strategy
16.7 Carestream Health
16.7.1 Company Overview
16.7.2 Financial Overview
16.7.3 Products Offering
16.7.4 Key Developments
16.7.5 SWOT Analysis
16.7.6 Key Strategy
16.8 Epic Systems
16.8.1 Company Overview
16.8.2 Financial Overview
16.8.3 Products Offering
16.8.4 Key Developments
16.8.5 SWOT Analysis
16.8.6 Key Strategy
16.9 IBM
16.9.1 Company Overview
16.9.2 Financial Overview
16.9.3 Products Offering
16.9.4 Key Developments
16.9.5 SWOT Analysis
16.9.6 Key Strategy
16.1 Allscripts Healthcare Solutions
16.10.1 Company Overview
16.10.2 Financial Overview
16.10.3 Products Offering
16.10.4 Key Developments
16.10.5 SWOT Analysis
16.10.6 Key Strategy
16.11 Cerner Corporation
16.11.1 Company Overview
16.11.2 Financial Overview
16.11.3 Products Offering
16.11.4 Key Developments
16.11.5 SWOT Analysis
16.11.6 Key Strategy
16.12 NextGen Healthcare
16.12.1 Company Overview
16.12.2 Financial Overview
16.12.3 Products Offering
16.12.4 Key Developments
16.12.5 SWOT Analysis
16.12.6 Key Strategy
16.13 Medical Information Technology, Inc.
16.13.1 Company Overview
16.13.2 Financial Overview
16.13.3 Products Offering
16.13.4 Key Developments
16.13.5 SWOT Analysis
16.13.6 Key Strategy
17 Appendix
17.1 Discussion Blue Print
17.2 Recent key developments
17.3 References

Additional information

Publisher

Geography Covered

Date Published

Pages

Format